A Tool for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionals.
Document Category: Medical and Behavioral Health
This webinar examines key insights from agencies that considered or have made the transition away from privatized healthcare, covering topics such as Improved Oversight, Staffing Challenges, Cost Considerations, and Quality of Care. Facilitated by Dr. Marc Stern, MD, MPH, the conversation features firsthand experiences, challenges, and best practices, also covering financial and operational impacts, helping facilities navigate informed decisions about the future of correctional healthcare.
The eight videos included in this resource are brief, informative videos to enhance learners’ awareness and foster a deeper understanding on topics related to substance withdrawal management. These videos also serve as tools to address myths and misconceptions about substance use, substance use disorders, and substance withdrawal.
For the first time, Medicaid is being authorized to cover some health services for individuals in the period before they are released from incarceration. This fact sheet summarizes recent changes that are taking effect.
Outline of maternal/pregnancy warning signs.
The objective of this study was to assess prison and jail pregnancy policies and practices with an emphasis on restraint use and compliance with anti-shackling legislation.
Authors describe jail healthcare staffing among jails in the southeast. Jails annually incarcerate millions of people with health problems, yet jail healthcare services have not been well described.
Examines the causal impact of mental health needs scores on youth and adult outcomes such as suicide attempts and incarceration duration.
The overdose crisis is claiming lives across the United States, but it reaches new depths of despair in the criminal justice system. Overdose is the leading cause of death among people returning to their communities after being in jail or prison. Providing addiction treatment in these settings could change that.
To identify implementation barriers and facilitators to the adoption and implementation of programs that provide opioid agonist treatments (OAT) with methadone and buprenorphine to treat opioid use disorder in jails and prisons in the United States.